| HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide L Luznik, PV O'Donnell, HJ Symons, AR Chen, MS Leffell, M Zahurak, ... Biology of Blood and Marrow Transplantation 14 (6), 641-650, 2008 | 1940 | 2008 |
| Characterization of clonogenic multiple myeloma cells W Matsui, CA Huff, Q Wang, MT Malehorn, J Barber, Y Tanhehco, ... Blood 103 (6), 2332-2336, 2004 | 1046 | 2004 |
| Blockade of hedgehog signaling inhibits pancreatic cancer invasion and metastases: a new paradigm for combination therapy in solid cancers G Feldmann, S Dhara, V Fendrich, D Bedja, R Beaty, M Mullendore, ... Cancer research 67 (5), 2187-2196, 2007 | 853 | 2007 |
| Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumors X Fan, W Matsui, L Khaki, D Stearns, J Chun, YM Li, CG Eberhart Cancer research 66 (15), 7445-7452, 2006 | 813 | 2006 |
| Cyclopamine-mediated hedgehog pathway inhibition depletes stem-like cancer cells in glioblastoma EE Bar, A Chaudhry, A Lin, X Fan, K Schreck, W Matsui, S Piccirillo, ... Stem cells 25 (10), 2524-2533, 2007 | 766 | 2007 |
| Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistance W Matsui, Q Wang, JP Barber, S Brennan, BD Smith, I Borrello, I McNiece, ... Cancer research 68 (1), 190-197, 2008 | 694 | 2008 |
| Transient low doses of DNA-demethylating agents exert durable antitumor effects on hematological and epithelial tumor cells HC Tsai, H Li, L Van Neste, Y Cai, C Robert, FV Rassool, JJ Shin, ... Cancer cell 21 (3), 430-446, 2012 | 691 | 2012 |
| Targeting Hedgehog—a cancer stem cell pathway AA Merchant, W Matsui Clinical cancer research 16 (12), 3130-3140, 2010 | 626 | 2010 |
| Hedgehog signaling maintains a tumor stem cell compartment in multiple myeloma CD Peacock, Q Wang, GS Gesell, IM Corcoran-Schwartz, E Jones, J Kim, ... Proceedings of the National Academy of Sciences 104 (10), 4048-4053, 2007 | 618 | 2007 |
| Prognostic significance of tumorigenic cells with mesenchymal features in pancreatic adenocarcinoma ZA Rasheed, J Yang, Q Wang, J Kowalski, I Freed, C Murter, SM Hong, ... Journal of the National Cancer Institute 102 (5), 340-351, 2010 | 531 | 2010 |
| High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease L Luznik, J Bolaños-Meade, M Zahurak, AR Chen, BD Smith, R Brodsky, ... Blood, The Journal of the American Society of Hematology 115 (16), 3224-3230, 2010 | 467 | 2010 |
| Hypoxia increases the expression of stem-cell markers and promotes clonogenicity in glioblastoma neurospheres EE Bar, A Lin, V Mahairaki, W Matsui, CG Eberhart The American journal of pathology 177 (3), 1491-1502, 2010 | 417 | 2010 |
| Association of Foxp3 regulatory gene expression with graft-versus-host disease Y Miura, CJ Thoburn, EC Bright, ML Phelps, T Shin, EC Matsui, ... Blood 104 (7), 2187-2193, 2004 | 402 | 2004 |
| DCLK1 marks a morphologically distinct subpopulation of cells with stem cell properties in preinvasive pancreatic cancer JM Bailey, J Alsina, ZA Rasheed, FM McAllister, YY Fu, R Plentz, H Zhang, ... Gastroenterology 146 (1), 245-256, 2014 | 335 | 2014 |
| A direct pancreatic cancer xenograft model as a platform for cancer stem cell therapeutic development A Jimeno, G Feldmann, A Suárez-Gauthier, Z Rasheed, A Solomon, ... Molecular cancer therapeutics 8 (2), 310-314, 2009 | 335 | 2009 |
| An orally bioavailable small-molecule inhibitor of Hedgehog signaling inhibits tumor initiation and metastasis in pancreatic cancer G Feldmann, V Fendrich, K McGovern, D Bedja, S Bisht, H Alvarez, ... Molecular cancer therapeutics 7 (9), 2725-2735, 2008 | 323 | 2008 |
| Nonmyeloablative HLA-haploidentical bone marrow transplantation with high-dose posttransplantation cyclophosphamide: effect of HLA disparity on outcome YL Kasamon, L Luznik, MS Leffell, J Kowalski, HL Tsai, J Bolaños-Meade, ... Biology of Blood and Marrow Transplantation 16 (4), 482-489, 2010 | 319 | 2010 |
| Risk-stratified outcomes of nonmyeloablative HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide SR McCurdy, JA Kanakry, MM Showel, HL Tsai, J Bolaños-Meade, ... Blood, The Journal of the American Society of Hematology 125 (19), 3024-3031, 2015 | 313 | 2015 |
| Cancer stem cell signaling pathways WH Matsui Medicine 95 (1S), S8-S19, 2016 | 307 | 2016 |
| A DNA hypermethylation module for the stem/progenitor cell signature of cancer H Easwaran, SE Johnstone, L Van Neste, J Ohm, T Mosbruger, Q Wang, ... Genome research 22 (5), 837-849, 2012 | 290 | 2012 |
Richard J JonesJohns Hopkins在 jhmi.edu 的电子邮件经过验证
